Abeona Therapeutics Inc. financial data

Symbol
ABEO on Nasdaq
Industry
Pharmaceutical Preparations
Location
6555 Carnegie Ave, 4 Th Floor, Cleveland, OH
State of incorporation
DE
Fiscal year end
December 31
Former names
PLASMATECH BIOPHARMACEUTICALS INC (to 6/4/2015), ACCESS PHARMACEUTICALS INC (to 8/14/2014), CHEMEX PHARMACEUTICALS INC (to 2/5/1996)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 596 % -0.14%
Debt-to-equity 215 % +3.04%
Return On Equity -227 % +2.27%
Return On Assets -72.2 % +4.23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.5M shares +75.5%
Common Stock, Shares, Outstanding 43.4M shares +75.6%
Entity Public Float 78.5M USD +173%
Common Stock, Value, Issued 434K USD +75.7%
Weighted Average Number of Shares Outstanding, Basic 48.1M shares +93.9%
Weighted Average Number of Shares Outstanding, Diluted 48.1M shares +93.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.5M USD +250%
Research and Development Expense 32.7M USD +9.21%
General and Administrative Expense 28M USD +48.5%
Operating Income (Loss) -60.7M USD -29.6%
Nonoperating Income (Expense) 745K USD +30.6%
Net Income (Loss) Attributable to Parent -71M USD -58.8%
Earnings Per Share, Basic -2.19 USD/shares +45.7%
Earnings Per Share, Diluted -2.64 USD/shares -31.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.7M USD +234%
Cash, Cash Equivalents, and Short-term Investments 110M USD +103%
Accounts Receivable, after Allowance for Credit Loss, Current 3.5M USD +250%
Assets, Current 113M USD +96.7%
Property, Plant and Equipment, Net 4.06M USD +1.48%
Operating Lease, Right-of-Use Asset 3.79M USD -19.1%
Other Assets, Noncurrent 88K USD
Assets 121M USD +82.5%
Accounts Payable, Current 2.79M USD +7.6%
Accrued Liabilities, Current 5.21M USD +31.2%
Liabilities, Current 18.4M USD +119%
Operating Lease, Liability, Noncurrent 3.4M USD -15.9%
Other Liabilities, Noncurrent 200K USD
Liabilities 74.8M USD +69.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -84K USD +15.2%
Retained Earnings (Accumulated Deficit) -804M USD -9.69%
Stockholders' Equity Attributable to Parent 45.8M USD +108%
Liabilities and Equity 121M USD +82.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.5M USD -23.8%
Net Cash Provided by (Used in) Financing Activities 25.4M USD
Net Cash Provided by (Used in) Investing Activities -7.82M USD -454%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 43.4M shares +75.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.09M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.1M USD +218%
Interest Paid, Excluding Capitalized Interest, Operating Activities 607K USD
Deferred Tax Assets, Valuation Allowance 109M USD +8.66%
Deferred Tax Assets, Gross 109M USD +8.66%
Operating Lease, Liability 4.46M USD -21.7%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 725K USD +233%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -71M USD -58.6%
Lessee, Operating Lease, Liability, to be Paid 5.42M USD -23.3%
Property, Plant and Equipment, Gross 18.5M USD +10.5%
Operating Lease, Liability, Current 1.06M USD -35.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 791K USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year One 853K USD -14.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 958K USD -30.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 807K USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 78.7M USD +4.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 823K USD +1.98%
Additional Paid in Capital 849M USD +12.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 116K USD -10.1%
Depreciation, Depletion and Amortization 491K USD -25.7%
Share-based Payment Arrangement, Expense 6.19M USD +51.4%
Interest Expense 3.24M USD +564%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%